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While ultrasonography is widely performed prior to biopsy, colour Doppler examination is often used only to discover post-
biopsy complications. Aim of this paper was to evaluate the usefulness of colour Doppler examination in planning the optimal
site of puncture for renal biopsy. Present analysis includes 561 consecutive percutaneous renal biopsies performed from the same
operator. Until August 2000 332 biopsies were performed after a preliminary ultrasonography (Group A). From September 2000,
229 patients underwent even a preliminary colour Doppler study (Group B). Postbioptic bleeding were categorized as minor
(gross hematuria or subcapsular perinephric hematoma < 4 cmq of greater diameter) or major (hematoma>4 cmq of greater
diameter; requiring blood transfusion or invasive procedures; leading to acute renal failure, urine tract obstruction, septicaemia,
or death). Major complications were seen in 2.1% in Group A while in Group B only one case was reported (0.43%). Minor
clinically signiﬁcant complications occur in 7.8% in Group A and in 3.4% of cases of Group B. Colour Doppler reduced drastically
the incidence of complications observed before the introduction of routine colour Doppler examination prior to biopsy. In our
opinion, these data support the use of preliminary colour Doppler study when a biopsy is planned.
1.Introduction
Percutaneous renal biopsy has become an essential tool in
the diagnosis and treatment of patients with renal disease,
and although less invasive, it is fraught with potential
complications. Introduction of realtime ultrasound and
automated biopsy needles increased quality of specimens
and dramatically reduced the incidence of biopsy-related
accidents [1–4]. Nonetheless, the potential for serious com-
plications still remains. On average, clinically signiﬁcant
complications occur in 7.4% of cases, but also complications
rates as high as 19.5% have been reported [1]. Many
variability in complication incidence attains certainly to
operator experience, but it is our opinion that a part of
this heterogeneity is linked to the attention paid in planning
correctly the optimal site of puncture, in order to avoid
undesired puncture of anomalous vessels.
While preprocedural ultrasonography is in fact widely
used to assess the anatomical landmarks of the kidney and
to exclude anatomical conditions considered as absolute
contraindications, to date, power and colour Doppler (CD)
examination are used less frequently in this setting, if not
only to discover postprocedural complications.
In our experience, anomalous perirenal vessels were
present in many biopsies complicated by renal bleeding.
In our Department, until August 2000, we performed a
total of 332 biopsies, using B-mode ultrasonography, only
occasionally integrated by CD study, in planning procedures.2 International Journal of Nephrology
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Figure 1: Colour Doppler US examination discloses perforant
artery (white arrow) at the inferior pole of left kidney (yellow
arrow).
From September 2000 all patients underwent a systematic
preliminary CD study prior to biopsy.
To investigate if this systematic approach reduced or
not complication incidence after procedure, we designed
a retrospective analysis of observed complications before
and after the systematic introduction of CD study in the
preparation of renal biopsy.
2.SubjectsandMethods
Present analysis includes 561 consecutive ultrasound-guided
percutaneous renal biopsies performed in our department
fromAugust1995toDecember2009fromthesameoperator.
Until August 2000, a total of 332 biopsies were per-
formed, after a B-mode ultrasonographic study of kidneys.
From September 2000 all patients (total 229) underwent a
preliminary systematic CD study prior to biopsy. In these
patients, vessels in the region of the biopsy were imaged
immediately before the procedure using CD ultrasonogra-
phy. Low pulse repetition frequency were used, between 750
and 1000Hz.
332patientsbiopsiedbeforeSeptember2000werenamed
Group A. The group of 229 patients systematically CD-
studied was named Group B.
Demographical data are listed in Table 1. Major and
minor complications were systematically registered in a
database. Postbiopsy complications were categorized as
either minor (gross hematuria and/or subcapsular per-
inephric hematoma < 4cmq of greater diameter) or major
(>4cmq of greater diameter; requiring transfusion of blood
products or invasive procedures; leading to acute renal
failure, urine tract obstruction, septicaemia, or death) [5, 6].
2.1. Biopsy Preparation. To minimize the risk of bleeding,
prothrombin time, partial thromboplastin time, bleeding
time (Ivy), and ﬁbrinogen were measured, using standard
methods, two hours prior to biopsy. Renal biopsy was not
performed if there were any abnormalities not liable to
correction. Salicilate, ticlopidine, and NSAIDs were with-
drawn for at least 7 days before biopsy. Use of heparin was
prohibited two days before biopsy. In case of arterial hyper-
tension under treatment, biopsy was performed only when
normotensiverangewasachieved(lessthen140/90mm/Hg).
Patients with renal cortex width < 10mm and/or < 90mm
of kidney longitudinal diameter were not considered suitable
for renal biopsy. All biopsies were performed using realtime
ultrasound-ﬁxed guidance (3.5MHz convex probe, Technos
MP; Esaote, Italy), and 16-gauge automated spring-loaded
gun. In all cases the lower pole of kidney was used for
biopsy, mainly at left side. Only in cases in which cysts,
small cortex, peri-renal vessels were detected in this location,
the right kidney was biopsied. In Group B, the presence of
medium-size arteries/veins at lower pole of left kidney was
an indication to perform biopsy on right kidney.
Single orthotopic kidneys (anatomically or functionally)
were not biopsied. One experienced nephrologist (AG)
performed all the biopsies.
Biopsy was performed in prone position with patients
lying with the abdomen on a ﬁrm pillow. The lower pole of
the kidney was located by ultrasound. The most appropriate
needle-skin angle was selected by adjusting the puncturing
adaptor (usually 20◦;s e eFigure 1). After disinfection of the
skin, lidocaine (1%) was applied locally under ultrasound
control along the needle insertion tract. A small incision of
the skin was made to facilitate the introduction of the biopsy
needle.UnderUSimagingguidancetheneedlewasadvanced
at an angle of 20◦until the capsule of the lower kidney
pole had been reached. Patients were asked to hold their
breath, the biopsy device was unlocked and tissue obtained.
The sampling time was <1s. Length of the obtained biopsy
specimens was usually 18–20 mm and at least two samples
were taken. Following the biopsy, patients lay in bed on
their backs for a 24-hour observation time. During this time,
both clinical (gross hematuria, ﬂank pain, and hypotension)
and imaging test (2-D realtime sonography, CD sonography,
and power Doppler sonography) were performed in order
to evaluate the presence and sizes of potential bleedings.
Blood pressure and pulse were monitored hourly. The
next morning, patients were mobilized after ultrasound
examination had ruled out major haematomas.
Statistical analysis was performed through Statistica 5.0
(StatSoft Inc.), using Fisher’s exact test. Statistical signiﬁ-
cance was set at P<0.05.
3. Results
Inallcasesspecimensshowedsuﬃcientmaterial.Meannum-
ber of glomeruli was 11 (range 7–43) per biopsy. Histological
analysis, including conventional light and immunoﬂuores-
cence microscopy, could be performed by the pathologist in
100% of cases. All complications registered during the study
are reported in Table 2.
In Group A an arteriovenous ﬁstula was observed in
one patient, and spontaneously resolved 18 months after
procedure. In Group B no ﬁstulas were detected.
Only in Group A two patients requested blood trans-
fusion for postprocedural acute anemization. One of thisInternational Journal of Nephrology 3
Table 1: Demographic data and diagnostic categories in 514 consecutive percutaneous renal biopsies.
Group A Group B P (A versus B)
Patients 332 229 —
Gender (m/f) 188/144 132/97 NS
Median age (years) 44.6 47.8 NS
Patients presenting with ARF 47 (14.1%) 31 (13.5%) NS
Patients with creatinine > 5mg/dL 45 (13.5%) 34 (14.8%) NS
Nephrotic syndrome 126 (37.9%) 85 (37.1%) NS
Diabetes 29 (8.7%) 21 (9.17%) NS
Urinary abnormalities 38 (11.4%) 26 (11.3%) NS
Hematuria 47 (14.1%) 32 (13.9%) NS
Table 2: Major and minor postbiopsy complications.
Group A Group B P
Major complications
Arteriovenous ﬁstula 1 0 —
Acute anemization requiring blood transfusion 2 0 —
Perirenal hematoma > 4cmq 3 1 —
Parenchymal bleeding requesting angiography 1 0 —
Total (%) 2.1 0.43 <0.05
Minor complications
Gross hematuria 16 5 <0.05
Small hematoma < 4cmq 10 3 <0.05
Total (%) 7.8 3.4 <0.005
two requested an angiographic procedure to stop bleeding,
through Gianturco method.
Three major hematomas (>4cmq) were observed in
Group A, while only one in Group B. In none of these
cases surgical procedures were indicated after urological
consulting.
Minor clinically signiﬁcant complications occur in 7.8%
of cases in Group A and in 3.4% of cases of Group B.
Microhematuria was highly frequent but it was not intended
as a complication.
Prebioptic CD evaluation showed anomalous vessels at
the lower pole of the right kidney in 15 patients and at the
lowerpoleofleftkidneyin19patients,respectively,asshown
in Table 3. In 15 of 19 patients with anomalous vessels at
the left kidney, it was impossible to identify an alternative
trajectory for the needle (Figures 1 and 2) and biopsy was
carried out on the right kidney. In the other 4 cases was
suﬃcient to accurately study the trajectory. Only one patient
in Group A underwent right kidney biopsy, showing a large
inferior pole simple cyst.
Anomalous interlobar vessels were observed in 9/229pts
while inferior pole arteries in 6 patients. Lower pole per-
forant arteries was reported in 5 patients. Only one patient
showed capsular vessels while two patients had paralumbar
plexus. Cumulatively 23pts (about 10% of whole Group
B) showed vascular abnormalities potentially at risk of
postprocedural bleeding.
Table 3: Vascular abnormalities at the colour doppler ultrasono-
graphic examination before biopsy.
Right kidney Left kidney
Lower pole perforant arteries 3 2
Inferior pole arteries 3 3
Capsular vessels — 1
Paralumbar plexus 1 1
Anomalous interlobar vessels 4 5
4. Discussion
Several authors [7–10] reported a drastic decrease in the
incidence of complications after renal biopsy when proce-
dure is guided by ultrasonography. Systematic use of colour
Doppler ultrasonography in monitoring patients after a
kidney biopsy, is crucial for an early diagnosis of postbiopsy
AV ﬁstula [11]. Perhaps if the importance of colour Doppler
ultrasonography in postprocedural evaluation [11–13]i s
clear and commonly accepted, its usefulness in preparing a
biopsy is yet to be appreciated.
This study, for the ﬁrst time, showed a systematic,
preparatory use of CD reduced postbiopsy complications
incidence, in the same unit and from the same operator. It
is to be underlined that during the time course of this study,
the operator experience in biopsy practice grew, probably
inﬂuencing in some part the results of this study. Perhaps it4 International Journal of Nephrology
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Figure 2: Colour Doppler US examination shows anomalous
capsular venous vessel (white arrow) at the inferior pole left kidney
(yellow arrow). Red arrow shows renal hilus.
is obvious that this study has all limitations of a retrospective
analysis. On the other hand it appears acceptable that
preliminary CD study helped operators to identify the safest
needle trajectory to the kidney, in some cases indicating
to prefer right organ for biopsy, even in absence of other
ultrasonographic indications to avoid left kidney puncture.
Data registered in our clinic before the default use
of CD study showed an incidence of major and minor
complications absolutely in line with those reported in the
literature [4–8]. The introduction of systematic CD study in
biopsy planning literally broke down both incidences.
CD module is largely available in most of ultrasonogra-
phersinuseinbiopsy-providingunits.Itdoesnotrequirethe
expositiontoionizingradiationsanddoesnotexposepatient
to any kind of risk. Perhaps it is an inexpensive tool, in term
of money, and its systematic use requests little eﬀort to the
nephrologist in term of time. Its systematic use can reduce
complications, and then costs, frequently as high as dramatic
from an ethical point of view. In other words it is an easy,
useful hand and sure tool in percutaneous renal biopsy.
On the other hand CD technique is highly operator-
dependent,requestingexperienceandskilltowarrantaﬀord-
able reliefs.
It is then to be underlined that CD module has to be used
when the nephrologist plans a biopsy, to design ideal needle
trajectory, and it is turned oﬀ when needle starts its descent
to the kidney. In this phase, obviously, CD could be only a
confounding factor for the operator, often used to vibrate
needle to make it visible on ultrasonographic screen.
This study opens a window on a new aspect in planning
kidney biopsies: the presence of anomalous vessels poten-
tially on the trajectory of biopsy needle. The systematic study
of kidneys showed in fact anomalous vessels in about 10%
of patients, giving a potential explanation to the observed
reduction in complications rate in CD-studied patients. It is
our opinion that this aspect could have more consideration
in planning the better strategy for kidney biopsy. Our data
show clearly as the same operator, in the same setting, could
obtain better results and drastically reduce complications
only enriching preliminary study with CD. It is obvious to
remind to the reader as vascular structures, particularly in
case of small ones, can slip from the attention even of a
well-skilled operator using only B-mode ultrasonography.
CD can help him to better clarify their nature and to identify
potential sources of risk in his strategy to biopsy.
On the basis of our data, clinically signiﬁcant postbiopsy
haematomas could potentially be related to small anomalous
vessels at the lower pole of kidneys. These insidious peculiar-
ities are, in our experience, relatively frequent. Experienced
nephrologist, planning a site of puncture for biopsy, has to
take care of them and design a strategy to reach renal cortex
without undesired experiences.
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